Changes to HIS 2024 Grants & Funding

Changes to HIS 2024 Grants & Funding

Supporting research in the field of infection prevention and control in healthcare is a vital HIS activity . In light of the current financial climate, we have made the difficult decision to reduce grant funding/frequency temporarily. This decision was not made lightly, but rather with the long-term sustainability of our society in mind. By reallocating resources, we aim to ensure the continued operation and growth of our organisation. We understand the impact this may have on your research and projects, and we remain committed to supporting you through other avenues such as educational events, networking opportunities, and access to resources.

Main grant changes:

  • Major research grant: will be allocated every other year instead of annually.
  • Small research grant: will have one grant allocated instead of two per year.
  • Graham Ayliffe Fellowship: Has increased to £80,000
  • All our other grants remain as they were.

We appreciate your understanding and ongoing dedication to advancing healthcare infection prevention and control and encourage our members to continue applying for the funding available.

Frequently asked questions

Position statements

We support following the Association of Medical Research Charities ‘Policy statements’ including:

Whilst the Society does not fund research using animals as part of its current strategy, we support the principle of using animals in research when it is necessary to advance understanding of serious health conditions to develop better treatments and there is no alternative that can be used to find out the same information without using animals.
The AMRC are committed to encouraging better practice and the developments of alternatives to animal use wherever possible, and all researchers are required to apply the highest standards of animal welfare in line with strict UK Home Office guidelines. When research is funded internationally, the expectation is that all research is carried out in the spirit of the UK legislation, in addition to being compliant with all required local legislation and ethical review procedures.

Scientific remit
  • We facilitate excellent research and collaboration between researchers and clinicians to reduce avoidable infections. We do this as we believe excellent research underpins clinical best practice
  • By supporting research we believe that improved patient outcomes and reductions in the rates of healthcare associated infections are achievable
  • We focus on research that will provide clinical impact and innovation in order to improve infection management, prevention and control in all healthcare settings
Who do you fund?

We fund people at all career stages from a range of disciplines including medicine, clinical science, engineering and public health, where they have shown an interest in infection prevention and control.

We fund researchers with the most innovative and exciting ideas. Our support can be for individuals or teams, and can include resources and equipment, or support for conferences and workshops.

With the exception of our travel grants, applicants must be based in the public sector within the UK and Republic of Ireland.  The eligibility requirements for each funding stream can be found on the individual award pages.

Applications must be for our research grants must be made by, or supervised by those in career grade or substantive positions.

Is my research within your remit?

We fund research that has direct impact on clinical practice and the spread of avoidable infections. Your research must address current and important clinical problems in a way that leads to an improvement in patient outcomes.  Therefore you must build upon clinical observations and use innovation in research or clinical practice.  We have designed our grants to support collaboration between clinicians and researchers. 

Infection Prevention and Control (IPC) is a scientific approach and practical implementation of methods to prevent harm caused by infection to both patients and healthcare workers.  IPC is a multi-disciplinary field which has patient safety and healthcare quality at its core, but also uses evidence from microbiology, epidemiology, engineering and behavioural science.  Healthcare associated infections are infections that develop as a direct result of a healthcare intervention or being in contact with a healthcare setting.

The scope of the society’s funding requires that applications be strictly related to healthcare associated infections and demonstrate clinical impact.   Applications in the broader fields of microbiology and biological sciences (including but not limited to mechanistic, molecular biology,  in vitro and genetic studies) that are not directly related to infection prevention and control do not sit within our remit. 

Please also read our Research Strategy for 2020-2025

Find out more about the people and research we've funded or contact us via


Finance and administration


We will only pay the direct costs of research.

For universities, the UK higher education funding bodies provide funding for directly allocated and indirect costs associated with charity-funded research.

In England, this funding is called the Charity Research Support Fund. Similar funding is provided by the Scottish Funding Council, Higher Education Funding Council for Wales and the Northern Ireland government.

For research conducted within the NHS, we follow AcoRD principles for non-commercial studies  available here

For non-commercial studies the normal funding arrangements for research, NHS Treatment and NHS Support costs are:

Research costs - are usually met by grant funders through the award of a research grant. However, there are some specific research activities where, in England, the costs will be met by the Department of Health.

NHS treatment costs - met through the normal commissioning process

NHS support costs - met from the research and development budget by the Health Departments of the United Kingdom

For further information please see the costings summary download above.


The host institution and primary grant holder are responsible for administering the award.  This includes formal standards, procedures, and audit and control arrangements.  The grant must be administered through a research support office or equivalent.



The Society does not co-fund research proposals and would only consider doing so in exceptional circumstances, if a particular joint call for applications was advertised. It is important that applicants state whether any financial support from another funding body is already provided or is being applied for on the application form. Please contact HIS for clarification prior to submitting an application if required.

Further details can be found in our Terms and Conditions of support.


HIS and National Institute for Health Research (NIHR)

HIS is a National Institute for Health Research (NIHR) non-commercial Partner. This means the studies that we fund may be eligible to access NIHR Clinical Research Network (CRN) support.

The NIHR Clinical Research Network (CRN) has extended support into health and social care research taking place in non-NHS settings.

The change to the policy (from 1 January 2018) means the CRN can support research conducted outside of NHS settings, such as studies running in care homes or in hospices, which will answer important questions for those patient populations. The CRN will also be able to better support research into public health, for example in schools and other community settings. This change is a way in which the NIHR is addressing the evolving health and care landscape and the changing needs of people and patients.

Read the full policy: Eligibility Criteria for NIHR Clinical Research Network Support.

In partnership with your local R&D office, we encourage you to involve your local CRN team in discussions as early as possible when planning your study to fully benefit from the support the NIHR CRN offers as outlined in their Study Support Service. To find out more about how you can apply for this additional support to help deliver your study, please visit

If your study involves NHS sites in England you will need to apply for Health Research Authority Approval. For guidance on submitting an application please visit: